RO-4584820

DB08094InvestigationalSmall molecule

RO-4584820: Overview.

Mechanism: Pharmacologically active on Cyclin-dependent kinase 2, Cyclin-dependent kinase 1, and Cyclin-dependent kinase 4
Curator reviewed
Formula / weight: C₁₈H₂₁F₂N₅O₄S · 441.452 g/mol (avg)
Code names: R-547 · RG-547 · RO-4584820

Resolves to

Compound

Structure

InChIKeyJRNJNYBQQYBCLE-UHFFFAOYSA-NSMILESCOC1=CC=C(F)C(F)=C1C(=O)C1=CN=C(NC2CCN(CC2)S(C)(=O)=O)N=C1N

Targets

What you can answer from here — as of June 15, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

19+ReferencesStructured and connected to the statements they support

Which drugs share a target with RO-4584820, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.